Skip to content
Research Article Open access CC BY 3.0

The Entrapment of Paclitaxel in PLGA Nanoparticles Increases its Cytotoxicity against Multiresistant Cell Line

Vanya Bojat, Vadim Balabanyan, Renad Alyautdin

Journal of Advances in Medicine and Medical Research · pp. 306–319 · Published 3 Aug 2011

10.9734/BJMMR/2011/382

Abstract

Paclitaxel (Ptx) is a taxane anticancer mitotic inhibitor, widely used in oncology for the last 20 years. Poor solubility of Ptx, as a consequence using of toxic solvents such as Cremofor EL, high affinity to P-glycoprotein are associated with serious side effects due to hypersensitivity reactions, low bioavailability and low therapeutic index. Development of new delivery solvent-free forms of Ptx is one of the key research problems in modern cancer chemotherapy. Ptx loaded into polylactic-co-glycolic acid (PLGA) nanoparticles (Ptx-PLGA-Nps) (size 200-300 nm) have been prepared using nanoprecipitation method. Impact of technological parameters on Ptx encapsulation efficacy and in vitro drug release was investigated. Drug encapsulation was determined using HPLC. Citotoxic activity and cell accumulation of nanosomal formulation of Ptx was studied on multiresistant cell line Jurkat WT (cells of human Т-limphoblastic leucosis). Obtained results suggest that formulation of PLGA Ptx nanoparticles have above 90-98% drug encapsulation efficacy, higher cell accumulation and cytotoxic activity.

Paclitaxel nanoparticles multiresistance P-glycoprotein

References (30)

  1. 1 Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer [DOI]
  2. 2 Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay [DOI]
  3. 3 Protein nanoparticles as drug carriers in clinical medicine [DOI]
  4. 4 Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity [DOI]
  5. 5 Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel.
  6. 6 Delivery of Loperamide Across the Blood-Brain Barrier with Polysorbate 80-Coated Polybutylcyanoacrylate Nanoparticles [DOI]
  7. 7 Novel formulations of taxanes: a review. Old wine in a new bottle? [DOI]
  8. 8 Nanoparticles of Biodegradable Polymers for Clinical Administration of Paclitaxel [DOI]
  9. 9 Paclitaxel nanoparticles for the potential treatment of brain tumors [DOI]
  10. 10 Phase I and Pharmacokinetics Trial of ABI-007, a Novel Nanoparticle Formulation of Paclitaxel in Patients With Advanced Nonhematologic Malignancies [DOI]
  11. 11 Multicenter Phase II Trial of ABI-007, an Albumin-Bound Paclitaxel, in Women With Metastatic Breast Cancer [DOI]
  12. 12 Commonly used surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats [DOI]
  13. 13 Nanoparticle Albumin-Bound Paclitaxel: A Novel Cremphor-EL ® -Free Formulation of Paclitaxel [DOI]
  14. 14 Toxicological studies of doxorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma [DOI]
  15. 15 Comparative scale-up of three methods for producing ibuprofen-loaded nanoparticles [DOI]
  16. 16 Biodistribution of polysorbate 80-coated doxorubicin-loaded [14C]-poly(butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing rats [DOI]
  17. 17 Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux [DOI]
  18. 18 Pharmacogenetics of paclitaxel metabolism [DOI]
  19. 19 The effect of P-glycoprotein on paclitaxel brain and brain tumor distribution in mice.
  20. 20 Self-Assembled Biodegradable Nanoparticles Developed by Direct Dialysis for the Delivery of Paclitaxel [DOI]
  21. 21 In vivo evaluation of lipid nanocapsules as a promising colloidal carrier for paclitaxel [DOI]
  22. 22 In vitro synergistic, antagonistic, and duration of exposure effects of metal cations on eukaryotic cells [DOI]
  23. 23 Paclitaxel loaded poly(l-lactic acid) (PLLA) microspheres [DOI]
  24. 24 Paclitaxel-induced apoptosis in Jurkat, a leukemic T cell line, is enhanced by ceramide [DOI]
  25. 25 Determination of the docetaxel vehicle, polysorbate 80, in patient samples by liquid chromatography–tandem mass spectrometry [DOI]
  26. 26 Lyoprotected Nanosphere Formulations for Paclitaxel Controlled Delivery [DOI]
  27. 27 Guanine nucleosides and Jurkat cell death: roles of ATP depletion and accumulation of deoxyribonucleotides [DOI]
  28. 28 Application of Fluorescence Microscopy to Measure Apoptosis in Jurkat T Cells After Treatment with a New Investigational Anticancer Agent (N.C.1213) [DOI]
  29. 29 Update on nanoparticle albumin-bound paclitaxel.
  30. 30 The MRD1 (P-glycoprotein) and MRP (P-190) transporters do not play a major role in the intrinsic multiple drug resistance of Jurkat T lymphocytes [DOI]

Cited by 17

Effect of Formulation Variables on the Release of Letrozole from Natural Biodegradable Polymeric Implants

S. Mehbuba Hossain, S. Islam, M. Saha · Journal of Pharmaceutical Research International · 2014

Biodegradable Nanoparticles Surface Modification Techniques With cIBR Peptide Targeting to LFA-1 Expressing Leukemic Cells

Rungsinee Phongpradist, Chuda Chittasupho, Nutjeera Intasai · Journal of Nanotechnology in Engineering and Medicine · 2012

Herceptin‐decorated salinomycin‐loaded nanoparticles for breast tumor targeting

R. Seda Tığlı Aydın · Journal of Biomedical Materials Research Part A · 2012

Etoposide encapsulation in surface‐modified poly(lactide‐co‐glycolide) nanoparticles strongly enhances glioma antitumor efficiency

Maïté Callewaert, Sylvain Dukic, Laurence Van Gulick · Journal of Biomedical Materials Research Part A · 2012

Development and evaluation of paclitaxel loaded PLGA:poloxamer blend nanoparticles for cancer chemotherapy

Prem N. Gupta, Sharad Jain, Chetan Nehate · International Journal of Biological Macromolecules · 2014

Dual drug-loaded paclitaxel–thymoquinone nanoparticles for effective breast cancer therapy

Parth Soni, Jasmine Kaur, Kulbhushan Tikoo · Journal of Nanoparticle Research · 2015

Showing 8 of 17 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

13

Page views

0

PDF downloads

0

Outbound clicks

17

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.